Cantargia reports Phase I/IIa data for cancer candidate CAN04

In October, Cantargia AB (SSE:CANTA) reported data from 1 patient in the Phase I/IIa CANFOUR

Read the full 157 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE